The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...
Avalyn's inhaled therapies use a nebuliser technology developed by PARI. Boston-based biotech Avalyn Pharma is the latest to hop on the IPO train, filing to list on the Nasdaq and raise funds for late ...
Healthcare in the UK is at an inflection point. To ensure the NHS remains fit for the future, the Government launched its 10-Year Health Plan for England last year, setting out strong ambitions around ...
Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results